Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Form 8.5 (EPT/RI)

30 May 2025 10:59

RNS Number : 8143K
Singer Capital Markets Sec Ltd
30 May 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Induction Healthcare Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Induction Healthcare Group Plc

(d) Date dealing undertaken:

29 May 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.5P

 

Purchases

 

114,592

 

9.36p

 

9.36p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

30 May 2025

Contact name:

Cindy Le

Telephone number:

020 7496 3171

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERURVKRVWUVORR
Date   Source Headline
27th Jul 202210:30 amRNSBlock Listing Six Monthly Return
11th Jul 20227:00 amRNSDistribution agreement for Zesty with System C
5th Jul 20227:01 amEQSEdison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare
7th Jun 20227:00 amRNSDirectorate Change
31st May 202212:58 pmRNSHolding(s) in Company
4th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
21st Apr 20227:00 amRNSPost-period end Trading Update
13th Apr 20224:01 pmRNSHolding(s) in Company
12th Apr 20224:00 pmRNSPurchase of Shares by Director
12th Apr 202212:11 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSPurchase of Shares by Directors
11th Apr 20227:00 amRNSNHS England contract renewals secure £6.6m ARR
7th Apr 20229:27 amRNSHolding(s) in Company
4th Apr 20227:00 amRNSFour London NHS Trusts sign with Induction Zesty
30th Mar 202211:00 amRNSAIM Rule 17 Schedule 2(g) Update
21st Mar 20227:00 amRNSNHS Scotland & Scottish Govt. Contract Renewals
26th Jan 20227:00 amRNSBlock Listing Six Monthly Return
6th Dec 20217:00 amRNSInduction AA rolls out new services nationwide
2nd Dec 202112:20 pmRNSPurchase of Shares by Directors
2nd Dec 20217:00 amRNSUnaudited Interim Results
26th Nov 20217:00 amRNSNotice of Half-year Results
15th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSInduction Attend Anywhere wins DWP contract
4th Nov 202110:52 amRNSResult of AGM
4th Nov 20217:00 amRNSAGM Statement
25th Oct 20217:00 amRNSReport on Video Consultations in Secondary Care
28th Sep 20217:00 amRNSPublication of Annual Report & Notice of AGM
23rd Sep 20217:00 amRNSFinal results for the year ended 31 March 2021
7th Sep 20217:00 amRNSDirectorate Changes
2nd Sep 20219:16 amRNSHolding(s) in Company
31st Aug 202111:04 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSBlock Listing Application
20th Jul 20217:00 amRNSMajor contract renewed with increased scope
16th Jun 20213:45 pmRNSHolding(s) in Company
11th Jun 20218:00 amRNSHolding(s) in Company
10th Jun 20214:18 pmRNSHolding(s) in Company
9th Jun 20218:00 amRNSCompletion of Acquisition of Attend Anywhere
8th Jun 20215:18 pmRNSHolding(s) in Company
7th Jun 202110:20 amRNSResult of General Meeting
21st May 20217:00 amRNSProposed Acquisition of Attend Anywhere Pty Ltd
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:06 amRNSSecond Price Monitoring Extn
18th May 202111:01 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSMultiple new hospital contracts for InductionZesty
25th Mar 20217:00 amRNSMulti-year hospital contract for Induction Switch
22nd Mar 20217:00 amRNSZesty surpasses 200k registered patients in the UK

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.